Earth Science Tech, Inc. revenue by segment ETST

Annual Quarterly

Earth Science Tech, Inc. splits its revenue into 3 lines in its filings. The largest line in fiscal 2026, which ended Mar 31, 2026 was Sale Of Pharmaceutical Products And Medical Consultations at $32.9 million, 92% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line	FY 2027 Jun 30, 2026	FY 2026 Mar 31, 2026	FY 2025 Mar 31, 2025	FY 2024 Mar 31, 2024	FY 2024 Mar 31, 2023	FY 2022 Mar 31, 2022	FY 2021 Mar 31, 2021	FY 2020 Mar 31, 2020	FY 2019 Mar 31, 2019	FY 2014 Mar 31, 2015	FY 2013 Mar 31, 2014
Revenue	—	36	33	12	0	0	0	1	1	0	0
Sale Of Pharmaceutical Products And Medical Consultations	—	33 +9.6% share 92.2%	30 share 90.7%	—	—	—	—	—	—	—	—
Shipping And Handling	—	2 -19.6% share 7.0%	3 share 9.3%	—	—	—	—	—	—	—	—
Other Revenue	—	0 share 0.8%	—	—	—	—	—	—	—	—	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Pharmaceutical Preparations (SIC 2834)
Listed as: ETST (OTC)
Fiscal year ends: March 31
Incorporated in: FL
Headquarters: Miami, FL
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 1538495
Former names: Ultimate Novelty Sports Inc. (until Apr 17, 2014)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.